Khaitan, CAM, Troutman Sanders, Simpson Thacher on Fosun’s acquisition of Gland Pharma for $1.26 billion

Bar & Bench July 29 2016

Shanghai Fosun Pharmaceutical, a leading Chinese health care provider, has signed an agreement to buy an 86 per cent stake in Hyderabad-based Gland Pharma for $1.26 billion (Rs.8,500 crore).

This is the largest acquisition of an Indian company by a Chinese firm and the biggest inbound M&A so far this year, reported ET.

This content is restricted to subscribers